Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact.

The company forecasts a full-year gross tariff impact of around $100 million from $80 million expected previously.

Alcon reported second-quarter sales of $2.58 billion, up 4% year over year, missing the consensus of $2.63 billion.

Also Read: Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition

Surgical net sales, which include implantables, consumables, and equipment/other, were $1.5 billion, an increase of 2% on a reported basis and 1% on a constant currency basis.

Implantables net sales were $456 million, a decrease of 2%, reflecting soft market conditions and competitive pressures.

Consumables net sales were $777 million, an increase of 6%. Excluding favorable currency impacts of ...